Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.
about
Human Th1 cells that express CD300a are polyfunctional and after stimulation up-regulate the T-box transcription factor eomesoderminThe environment of regulatory T cell biology: cytokines, metabolites, and the microbiomeSubcellular localization of FOXP3 in human regulatory and nonregulatory T cellsDicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieuThe PD-1 pathway in tolerance and autoimmunitySeparation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantationA homozygous CARD9 mutation in a family with susceptibility to fungal infectionsDisrupted regulatory T cell homeostasis in inflammatory bowel diseasesRegulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in TransplantationRegulation generation: the suppressive functions of human regulatory T cellsT Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T CellsRegulatory T cells in autoimmune neuroinflammationHomeostasis and function of regulatory T cells in HIV/SIV infectionThe role of regulatory T cells in the pathogenesis of sepsis and its clinical implicationCell therapy to induce allograft tolerance: time to switch to plan B?Subsets of regulatory T cells and their roles in allergyIdentification and In Vitro Expansion of Functional Antigen-Specific CD25+ FoxP3+ Regulatory T Cells in Hepatitis C Virus InfectionLevel, phenotype and activation status of CD4+FoxP3+regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virusEpidemiology and interactions of Human Immunodeficiency Virus – 1 and Schistosoma mansoni in sub-Saharan AfricaTregs and kidney: From diabetic nephropathy to renal transplantationClinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current PerspectivesMultiple Sclerosis and T Lymphocytes: An Entangled StoryProgressive activation of CD127+132- recent thymic emigrants into terminally differentiated CD127-132+ T-cells in HIV-1 infectionHow regulatory T cells workCirculating immune cells in multiple sclerosis.Flow cytometry imaging identifies rare T(H)2 cells expressing thymic stromal lymphopoietin receptor in a "proallergic" milieu.Human regulatory T cells inhibit polarization of T helper cells toward antigen-presenting cells via a TGF-beta-dependent mechanism.CD45RA distinguishes CD4+CD25+CD127-/low TSDR demethylated regulatory T cell subpopulations with differential stability and susceptibility to tacrolimus mediated inhibition of suppression.At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction.IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection.Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapyThe frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesisClinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservationResting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapyEffects of natalizumab treatment on Foxp3+ T regulatory cells.Interleukin-7 is decreased and maybe plays a pro-inflammatory function in primary immune thrombocytopenia.Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.The development of a comparison approach for Illumina bead chips unravels unexpected challenges applying newest generation microarrays.Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expressionIncreased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system.
P2860
Q21091134-40999D73-329F-431C-9698-B29F1352282CQ21131158-994C4B2C-7C78-489B-81DA-DCF5D2013FFDQ24337573-0F678A01-12A1-4327-B85B-7048B65F9B5FQ24625814-EBF6B128-21DE-4177-B45D-BA06D2C8B23CQ24633549-33B97AFB-1636-45AA-A3BB-96A8A1B00C80Q24642254-5BD41ADF-1664-4170-AC6E-2EEAEA8D2646Q24658090-C8B5DB95-D028-4F8A-AFB1-089D06530822Q26774590-CB3CBF74-BF2B-4D02-BEFA-37D1464EBFDDQ26784460-6C95B2EB-E65C-4612-A105-EF06DC5E0F85Q26823216-14C3958C-BE08-414A-BF1B-D2F8B19AB07FQ26823613-7C4EEEB6-8369-48AE-84FB-08CF11B403FCQ26825063-5294599F-C42E-4B5A-AFFC-EEA0D959DBE8Q26995345-020EEEE9-4F60-4828-AEEA-B84AEED26883Q27004368-F5A8B7AE-3871-405B-A750-F8017993646CQ27013040-851C13B7-F5A9-486E-BAA1-3D3B3D739670Q27024217-341BD3D5-9660-48D7-9321-081E4A763509Q27485897-08AB38D5-17E7-42A4-9A5E-97C13BA8EF64Q27488287-E5E59A0B-13B2-4B7D-990D-5A500426A558Q27499293-721F2D44-E6D8-4915-95B3-57BC08104AB5Q28066728-B72A883C-5FD7-4FA7-860C-BBDB871777D4Q28069832-CD7B9515-35EC-45FD-AE81-4A8ACBD78044Q28086853-5ACD2C59-8B29-478D-A788-B51FF1E976EBQ28732117-AB0D9003-E7B1-4D86-B233-791F85A48A14Q29614262-848B10D4-556F-461D-955F-CDB65A9C1D65Q30242026-3F13A07D-20FF-4B5D-AF3E-8DF87214EC0BQ30429961-D7E339D1-E691-4A2B-9B10-2C8812B5482AQ30481481-1662F79E-0671-4DA9-92E8-1D83DE7423D2Q30489628-041892CC-CD15-426D-88B4-1E64D2A00F7DQ33268352-EF5903D0-E14D-4200-8920-298703C54E66Q33327498-492C6B5C-504A-4440-B89B-0F04CB41755FQ33336577-39EF0CF2-33FE-4381-8730-88FB1CFB7E67Q33355836-51595248-D3F5-4FDD-9BE8-B95DB7AB7DF9Q33367565-EFEA6EAB-6519-498D-8399-CE5C424493BFQ33373073-951223E6-F07A-48D2-A93B-87079FCF6335Q33373995-8A57C5F2-E25A-4D04-89AA-2D364FFDFC38Q33414739-2CEA5C1B-0DB2-465C-AD26-4956DA088527Q33434467-1A15D16C-6EF8-49A0-9F4F-3F501C2138D2Q33470683-15A07E54-EDBD-42BD-B879-B7485493ECEBQ33471458-9E7CA6B5-4C7E-4CC8-B5CF-898CD19BB20CQ33490992-0736F654-D0A6-4006-8C5A-50132B8533EF
P2860
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Expression of interleukin (IL) ...... ulatory and activated T cells.
@ast
Expression of interleukin (IL) ...... ulatory and activated T cells.
@en
type
label
Expression of interleukin (IL) ...... ulatory and activated T cells.
@ast
Expression of interleukin (IL) ...... ulatory and activated T cells.
@en
prefLabel
Expression of interleukin (IL) ...... ulatory and activated T cells.
@ast
Expression of interleukin (IL) ...... ulatory and activated T cells.
@en
P2093
P2860
P50
P356
P1476
Expression of interleukin (IL) ...... ulatory and activated T cells.
@en
P2093
Alan Landay
Anthony Kelleher
Brigitte Santner-Nanan
Jeff Martinson
John Zaunders
Nabila Seddiki
Ralph Nanan
Stephen I Alexander
Warwick Selby
P2860
P304
P356
10.1084/JEM.20060468
P407
P577
2006-07-03T00:00:00Z